Management dilemmas in low-risk prostate cancer

BJU Int. 2016 Aug;118(2):180-1. doi: 10.1111/bju.13543.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Male
  • Prostate-Specific Antigen*
  • Prostatic Neoplasms*
  • Risk

Substances

  • Prostate-Specific Antigen